|
Volumn 17, Issue 4, 2001, Pages 283-290
|
A phase II trial testing the thermal dose parameter CEM43°T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy
a a a a a a a a a a a |
Author keywords
Complete response; Hyperthermia; Metastasis; Radiation therapy
|
Indexed keywords
ADULT;
AGED;
ARTICLE;
CANCER CONTROL;
CANCER GRADING;
CANCER LOCALIZATION;
CANCER RADIOTHERAPY;
CANCER SIZE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EVALUATION;
FEMALE;
HISTOLOGY;
HUMAN;
HYPERTHERMIC THERAPY;
MALE;
MEGAVOLTAGE RADIOTHERAPY;
METASTASIS;
PARAMETER;
PEROPERATIVE CARE;
PREDICTION;
PROSPECTIVE STUDY;
RADIATION BEAM;
RADIATION DOSE FRACTIONATION;
SOFT TISSUE SARCOMA;
TEMPERATURE MEASUREMENT;
THERMOMETRY;
TIME;
TOXICITY TESTING;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
EID: 0034944237
PISSN: 02656736
EISSN: None
Source Type: Journal
DOI: 10.1080/02656730110039449 Document Type: Article |
Times cited : (47)
|
References (21)
|